Clinical Utility of Microarray-Derived Genetic Signatures in Predicting Outcomes in Prostate Cancer-Reference-Cited by-同舟云学术

Clinical Utility of Microarray-Derived Genetic Signatures in Predicting Outcomes in Prostate Cancer

Published:2006-12 Issue:3 Volume:5 Page:187-189
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Reddy G. Kesava,Balk Steven P.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference13 articles.

1. Gene expression profiling predicts clinical outcome of prostate cancer;Glinsky;J Clin Invest,2004

2. Gene expression profiling identifies clinically relevant subtypes of prostate cancer;Lapointe;Proc Natl Acad Sci U S A,2004

3. Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior;Latil;Clin Cancer Res,2003

4. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease;LaTulippe;Cancer Res,2002

5. Tissue microarrays for high-throughput molecular profiling of tumor specimens;Kononen;Nat Med,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accurate prognosis for localized prostate cancer through coherent voting networks with multi-omic and clinical data;2022-07-31

2. Limitations of Explainability for Established Prognostic Biomarkers of Prostate Cancer;Frontiers in Genetics;2021-07-22

3. Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review;Biomedicine Hub;2017-05-17

4. Neural Cell Adhesion Molecules Belonging to the Family of Leucine-Rich Repeat Proteins;Advances in Neurobiology;2013-10-17

5. Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma;International Journal of Cancer;2011-03-25